Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.
In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers. Through its Networked Inspection Systems division, the company offers machine-vision inspection equipment designed to meet stringent quality standards and regulatory requirements. Stevanato’s manufacturing capabilities also extend into polymer primary packaging and high-precision molding, enabling a broader portfolio of container formats.
Founded in 1949 and headquartered in Piombino Dese, Italy, Stevanato Group has expanded its footprint with manufacturing sites and engineering centers across Europe, North America, Latin America and Asia. Key production facilities are located in Italy, the United States, Brazil, Slovakia and China. This global presence allows the company to serve multinational pharmaceutical and biotech firms as well as contract development and manufacturing organizations (CDMOs).
Under the leadership of Chief Executive Officer Paolo Dellachà, Stevanato Group emphasizes innovation, sustainability and digitalization in its operations. The company invests in research and development to advance containment materials, processing technologies and inspection automation. With a focus on environmental stewardship and patient safety, Stevanato continues to evolve its offerings to meet the dynamic needs of the life sciences sector.
AI Generated. May Contain Errors.
Free STVN Stock Alerts